Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Ming-yu Lien

Clinical trials sponsored by Ming-yu Lien, explained in plain language.

Trials to join now! 1

Immunotherapy plus chemo may turn inoperable esophageal cancer into surgical candidates

Disease control Recruiting now

This Phase 2 trial is testing whether adding the immunotherapy drug tislelizumab to standard chemoradiotherapy can shrink advanced esophageal tumors enough to allow surgery. About 45 people with unresectable esophageal squamous cell carcinoma will receive the combination, followe…

Phase 2 • Sponsor: Ming-Yu Lien • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC